Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Mirabile

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Diagnostics (Basel, Switzerland)|December 30, 2025
Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid LeukemiaSabina Russo, Manlio Fazio, Giuseppe Mirabile, et al.
International Journal of Molecular Sciences|October 16, 2025
Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted TherapyRita Badagliacca, Manlio Fazio, Fabio Stagno, et al.
Current Medicinal Chemistry|June 2, 2022
New Insights into Cold Shock Proteins Effects in Human Cancer: Correlation with Susceptibility, Prognosis and Therapeutical PerspectivesGiuseppe Mirabile, Chiara Campo, Roberta Ettari, et al.
Biomedicines|April 29, 2025
Using Artificial Intelligence to Enhance Myelodysplastic Syndrome Diagnosis, Prognosis, and TreatmentFabio Stagno, Giuseppe Mirabile, Patricia Rizzotti, et al.
Cancers|September 9, 2022
Critical Role of Aquaporins in Cancer: Focus on Hematological MalignanciesAlessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase InhibitorsAlessandro Allegra, Giuseppe Mirabile, Santino Caserta, et al.
International Journal of Molecular Sciences|December 11, 2025
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> MutationFederico Pierro, Stefania Stella, Manlio Fazio, et al.
International Journal of Molecular Sciences|March 27, 2025
Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid LeukemiaFabio Stagno, Sabina Russo, Giuseppe Murdaca, et al.
Pathology, Research and Practice|May 22, 2023
The role of High-mobility group box-1 and Psoriasin in multiple myeloma: Analysis of a population affected by monoclonal gammopathies and review of the literatureMarco Casciaro, Donatella Vincelli, Maria Ferraro, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Diagnostics (Basel, Switzerland)|December 30, 2025
Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid LeukemiaSabina Russo, Manlio Fazio, Giuseppe Mirabile, et al.
International Journal of Molecular Sciences|October 16, 2025
Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted TherapyRita Badagliacca, Manlio Fazio, Fabio Stagno, et al.
Current Medicinal Chemistry|June 2, 2022
New Insights into Cold Shock Proteins Effects in Human Cancer: Correlation with Susceptibility, Prognosis and Therapeutical PerspectivesGiuseppe Mirabile, Chiara Campo, Roberta Ettari, et al.
Biomedicines|April 29, 2025
Using Artificial Intelligence to Enhance Myelodysplastic Syndrome Diagnosis, Prognosis, and TreatmentFabio Stagno, Giuseppe Mirabile, Patricia Rizzotti, et al.
Cancers|September 9, 2022
Critical Role of Aquaporins in Cancer: Focus on Hematological MalignanciesAlessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase InhibitorsAlessandro Allegra, Giuseppe Mirabile, Santino Caserta, et al.
International Journal of Molecular Sciences|December 11, 2025
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> MutationFederico Pierro, Stefania Stella, Manlio Fazio, et al.
International Journal of Molecular Sciences|March 27, 2025
Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid LeukemiaFabio Stagno, Sabina Russo, Giuseppe Murdaca, et al.
Pathology, Research and Practice|May 22, 2023
The role of High-mobility group box-1 and Psoriasin in multiple myeloma: Analysis of a population affected by monoclonal gammopathies and review of the literatureMarco Casciaro, Donatella Vincelli, Maria Ferraro, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
Pageof 2